1. CLINICAL, PARACLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF PATIENTS WITH MILD ACUTE ISCHEMIC STROKE AT THE EMERGENCY DEPARTMENT OF TRANSPORT HOSPITAL IN 2024
Main Article Content
Abstract
Objective: To describe the clinical and paraclinical characteristics and treatment outcomes of patients with mild acute ischemic stroke at the Emergency Department of Transport Hospital.
Methods: A cross-sectional study was conducted on 31 patients aged ≥18 years diagnosed with mild acute ischemic stroke (NIHSS ≤4) admitted within 24 hours of symptom onset and treated at Transport Hospital from July 2023 to October 2024. Data collected included clinical manifestations, laboratory findings, neuroimaging results, TOAST classification, treatment approaches, and discharge status. Data analysis was performed using SPSS 20.0, with statistical significance set at p<0.05.
Results: Patients’ ages ranged from 49 to 93 years, with a nearly equal male-to-female ratio (48.4% vs. 51.6%). The most common symptoms were hemiparesis (32.3%), dysarthria (22.6%), and sensory disturbances (19.4%). Hypertension was the predominant risk factor (>75%). Brain lesions were mainly located in the basal ganglia (45.2%), cerebral lobes (25.8%), and subcortical regions (16.1%). Small-vessel disease was the most frequent etiology (48.3%). All patients received conservative medical treatment, with no deaths or referrals reported.
Conclusion: Mild acute ischemic stroke has favorable short-term outcomes; however, potential risks of disability and recurrence remain. Early detection, strict vascular risk factor control, and long-term management strategies are essential.
Article Details
Keywords
ischemic stroke, mild stroke, risk factors, prognosis
References
[2] Feigin VL, Brainin M, Norrving B, Gorelick PB, Dichgans M, Wang W, et al. What is the best mix of population-wide and high-risk targeted strategies of primary stroke and cardiovascular disease prevention? Int J Stroke. 2020;15(2):205-12. doi:10.1177/1747493019879659.
[3] Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082-90. doi:10.1161/STROKEAHA.108.540781.
[4] Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-25. doi:10.1056/NEJMoa1800410.
[5] Wang Y, et al. Factors associated with delayed hospital arrival in patients with acute ischemic stroke in China: a multicenter cross-sectional study. Neurol Res. 2011;33(5):494-9. doi:10.1179/016164111X13007856084405.
[6] Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson DM, Hernandez AF, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines–Stroke. Stroke. 2011;42(11):3110-5. doi:10.1161/STROKEAHA.111.613208.
[7] O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-23. doi:10.1016/S0140-6736(10)60834-3.
[8] Amarenco P, Lavallée PC, Labreuche J, Albers GW, Bornstein NM, Canhão P, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533-42. doi:10.1056/NEJMoa1412981.
[9] Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689-701. doi:10.1016/S1474-4422(10)70104-6.
[10] Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD, et al. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke. 2012;43(4):1013-7. doi:10.1161/STROKEAHA.111.637421.